|
 |
|
IFC Financing Supports Growth and Competitiveness of Indian Pharmaceutical Firm, Granules |
|
In New Delhi:
Minakshi Seth
Phone: +91 11 4111 1058
Email: mseth@ifc.org
In Washington, DC:
Carmen Powell
Phone: +1 (202) 473-4982
Email: cpowell@ifc.org
|
New Delhi, India, June 14, 2007 – IFC, the private
sector arm of the World Bank Group, today announced an agreement to provide
financing for Granules India Limited, a decision that will help the company
strengthen its financial position and expand its existing business, helping
more people across the income spectrum to access the medicines they need.
The company will use the $15 million investment—loans
of up to $9 million and up to $6 million in equity—to expand its active
pharmaceutical ingredient and granulation capacities, while vertically
integrating into finished formulations. At project completion, Granules
will have added significant scale capacities for its target markets, which
will enhance the company’s competitiveness.
“We feel that this relationship gives us a wider horizon
to explore possibilities for innovative financing,” said Krishna Prasad,
Managing Director of Granules. “We were very impressed with IFC’s thorough
due diligence on our financial and environmental policies. We see IFC support
as an endorsement of our emphasis on world-class infrastructure and global
vision,” he added.
Dimitris Tsitsiragos, IFC Director of Global Manufacturing
and Services, commented, “Our investment will provide financing to Granules
over a longer-term horizon, essential for the company’s growth strategy.
We believe that the company has put together a capable management team
to harness the market opportunities.”
“Our investment in Granules is another example of IFC’s
continued focus on supporting mid-tier Indian companies with long-term
debt and equity investment,” noted Sujoy Bose, IFC Senior Manager for
South Asia. “Through this project, IFC will help Granules build on its
economies of scale, vertical integration, and regulatory experience and
move up the value chain into finished formulation manufacturing,” he added.
About IFC
IFC, the private sector arm of the World Bank Group, promotes
open and competitive markets in developing countries. IFC supports sustainable
private sector companies and other partners in generating productive jobs
and delivering basic services, so that people have opportunities to escape
poverty and improve their lives. Through FY06, IFC Financial Products have
committed more than $56 billion in funding for private sector investments
and mobilized an additional $25 billion in syndications for 3,531 companies
in 140 developing countries. IFC Advisory Services and donor partners have
provided more than $1 billion in program support to build small enterprises,
to accelerate private participation in infrastructure, to improve the business
enabling environment, to increase access to finance, and to strengthen
environmental and social sustainability. For more information, please visit
www.ifc.org.
IFC in India
IFC’s $1.3 billion portfolio in India (as of June 2006)
makes it our fourth-largest country exposure. In FY06, we committed over
$400 million in new investments in the country. Our cumulative project
commitments in the country since 1956 total $3.3 billion. We support private
sector–led development through direct investment and advisory services
that promote growth and competitiveness.
About Granules
Granules India Limited is a leading contract manufacturer
of active pharmaceutical ingredients and pharmaceutical formulation intermediates.
The Hyderabad based company is a major international supplier, primarily
of paracetamol and ibuprofen-based products. The manufacturing facilities
of the company have been approved by the United States Food and Drug Administration
and other foreign regulatory agencies.
|
 |
| |
 |
|
|
|